Over time, researchers have found that the pathway of PD-1/PD-L1 also plays an essential role in the resolution of stroke-related neuroinflammation, the decrease in immune function that occurs in patients with OSAHS, and the inflammation that occurs in AKI. The gene discussed is CD274; the disease is stroke disorder.